Related Experiment Video
Updated: May 20, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Third ventriculostomy in infants younger than 1 year old
José Aloysio Costa Val1, Paulo Mallard Scaldaferri, Leopoldo Mandic Furtado
1Pediatric Neurosurgery Department, Biocor Instituto, Nova Lima, MG, Brazil. costaval.bh@terra.com.br
Insights
Endoscopic third ventriculostomy (ETV) is effective for hydrocephalus treatment, with success rates depending on the cause, not patient age. This neurosurgical procedure shows higher success in aqueductal stenosis compared to Chiari type II.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Hydrocephalus Management
Background:
- Endoscopic third ventriculostomy (ETV) is increasingly utilized for hydrocephalus treatment.
- Previous studies debated ETV's efficacy in infants under one year old.
- Emerging evidence suggests hydrocephalus etiology, not patient age, is key to ETV success.
Purpose of the Study:
- To retrospectively evaluate the effectiveness of ETV in hydrocephalus treatment.
- To determine if patient age or hydrocephalus etiology influences ETV success rates.
Main Methods:
- Retrospective analysis of 75 endoscopic procedures, including 48 ETVs.
- Patient groups were stratified by hydrocephalus etiology: aqueductal stenosis, Dandy-Walker malformation, and Chiari type II malformation.
- Success rates were analyzed based on etiology and age groups.
Main Results:
- ETV success rates varied significantly by etiology: 90% for aqueductal stenosis, 50% for Chiari type II.
- No statistically significant difference in ETV success was observed when patients were stratified by age groups.
- Etiology-driven outcomes highlight specific indications for ETV.
Conclusions:
- The effectiveness of ETV in hydrocephalus treatment is primarily linked to the underlying etiology.
- Patient age is not a significant factor in determining ETV success.
- ETV is a viable treatment for hydrocephalus, with outcomes dependent on the specific cause.
Introduction:
Endoscopic third ventriculostomy (ETV) gains more attention each day in the treatment of hydrocephalus. Some authors have questioned the effectiveness of the procedure for the treatment of infants younger than 1 year. More recent studies revealed that the effectiveness of the procedure is more related to the etiology of the disease than to the age of the patient.
Materials And Methods:
We studied retrospectively the effectiveness of third ventriculostomy in our service: 75 endoscopic procedures, from which 48 were ETVs. Among the ETVs, 30 were used to treat aqueductal stenosis, three for Dandy-Walker, eight for Chiari type II.
Results:
When the patients were stratified by the etiology of the hydrocephalus, there was a statistically significant difference among the groups studied with higher success among patients with aqueductal stenosis the (90 %) and lower for the treatment of Chiari II-related hydrocephalus (50 % of success). With the patients stratified by age groups, there was no significant difference in terms of the success of the treatment.
Conclusion:
Our results have shown that the effectiveness of ETV is not actually age-related, but etiology-related.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Anatomy of the Brain: Ventricles
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
